BioSpace News Archive

Press Releases

IO Biotech Completes Enrollment in Phase 2 Trial of its Investigational, Off-the-shelf Therapeutic Cancer Vaccine, IO102-IO103, as Neoadjuvant/Adjuvant Treatment for Patients with Resectable Melanoma or Head and Neck Cancer

January 9, 2025
·
7 min read
Press Releases

Boehringer Ingelheim Acquires Fourth License for the Development of Novel Antibody Based Cancer Treatments from Oxford BioTherapeutics

January 9, 2025
·
3 min read
Press Releases

SimBioSys Appoints Stacey Stevens as President and CEO

January 9, 2025
·
3 min read
Press Releases

Anumana Appoints Dr. Simos Kedikoglou as President and Chief Operating Officer

January 9, 2025
·
3 min read
Press Releases

Biocytogen Announces Licensing of Fully Human Antibodies with SOTIO to Develop Novel ADC SOT109 for Colorectal Cancer Treatment

January 9, 2025
·
4 min read
Press Releases

Agendia, Inc. Provides Review of Successful 2024

January 9, 2025
·
7 min read
Press Releases

Elegen Now Ships Plasmids Up to 15 kb in Just 10 Business Days, Bringing Unprecedented Speed to Long DNA Synthesis

January 9, 2025
·
2 min read
Press Releases

Vensana Capital Closes $425 Million Fund III to Back Breakthrough Medical Technology Companies

January 9, 2025
·
3 min read
Press Releases

SOTIO Advances Colorectal Cancer ADC Program, SOT109, and Licenses Fully Human Antibodies from Biocytogen for Novel Tumor Target

January 9, 2025
·
4 min read
Press Releases

Cadenza Bio, Inc. Announces Members of the Women’s Health Scientific Advisory Board

January 9, 2025
·
2 min read